CCL2 and lung cancer: Given our previous observation that blocking CCL2 inhibited the lung cancer-promoting effects of HDM exposure (14), and considering that CCR2, the main CCL2 receptor, is highly expressed on monocytes and crucial for their recruitment to inflammatory sites (90), we speculate that HDM exposure triggers cMos recruitment to the lungs.